What is the role of methylprednisolone in the treatment of diabetic lumbosacral plexopathy?

Updated: Jan 04, 2021
  • Author: Divakara Kedlaya, MBBS; Chief Editor: Milton J Klein, DO, MBA  more...
  • Print

Another study, by Dyck et al, suggested that methylprednisolone is effective against diabetic lumbosacral radiculoplexus neuropathy. The double-blind, placebo-controlled study involved 75 patients with the condition, who were randomized to a 12-week regimen of intravenous methylprednisolone or placebo. [41] Although the study’s primary outcome (time to improvement of neuropathy impairment score) was not significantly different between the 2 groups, patients treated with methylprednisolone reported significantly greater symptom improvement, particularly with regard to measures of pain and positive sensory symptoms.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!